Local insulin application on the carotid artery inhibits neointima formation

Area of Science:

• Cardiovascular Research
• Vascular Biology
• Pharmacology

Background:

• Current anti-mitogenic agents for drug-eluting stents delay re-endothelialization, increasing late stent thrombosis risk.
• Systemic insulin treatment accelerates re-endothelialization and reduces neointimal growth but poses hypoglycemia risks in non-diabetic patients.

Purpose of the Study:

• To investigate the efficacy of local insulin treatment in reducing neointimal growth and promoting re-endothelialization after arterial injury.
• To determine if local insulin delivery can mitigate restenosis without systemic side effects.

Main Methods:

• Rats underwent balloon angioplasty of the carotid artery.
• Local insulin or vehicle was delivered via Pluronic gel around the injured artery.
• Neointimal area and vascular smooth muscle cell migration were assessed at 4 and 28 days.

Main Results:

• Local insulin treatment significantly decreased intimal area at 28 days (P < 0.05).
• Insulin inhibited vascular smooth muscle cell migration by 60% at 4 days (P < 0.05).
• Local insulin administration did not affect plasma glucose or systemic insulin levels.

Conclusions:

• Local insulin treatment effectively reduces neointimal hyperplasia and promotes vascular healing after arterial injury.
• This localized approach offers a potential therapeutic strategy for preventing restenosis, possibly through insulin-eluting stents.
• Insulin demonstrates a protective vascular effect in vivo, independent of systemic glycemic control.